STAT+: Pharmalittle: We’re reading about a closing loophole for importing meds, European competitiveness, and more
As of next month, a loophole that allows Americans to personally import their medications by mail is closing
A closing loophole allows Americans to personally import their medications as of next month, according to The Wall Street Journal. On October 22, a rule will take effect mandating medications mailed from abroad to go through a customs process involving a licensed broker and a financial guarantee. This move aims to combat illegal contraband entering the country through low-value foreign shipments that don't pay tariffs or submit data for tracking.
A study published in The New York Times found that over 1.1 million U.S. adults were taking GLP-1 medications without a medical reason, as identified through an analysis of more than 92 million U.S. adults' medical records. These medications, like Ozempic, are often used for weight loss or to potentially provide other health benefits.
While the researchers did not investigate the reasons behind these individuals taking these medications, doctors suggested that many likely use them to shed pounds or hope for additional health advantages.
Written by urgent.news from STAT News's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
